Search research articles
Contact Us
Filters
Showing results (101-110 of 138) with videos related to
Page
of 14
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
October 24, 1995
Development of a safe live Leishmania vaccine line by gene replacement
R G Titus, F J Gueiros-Filho, L A de Freitas, et al.
Molecular and Biochemical Parasitology
|
October 1, 1993
Reversion to virulence in Leishmania major correlates with expression of surface lipophosphoglycan
A Shankar, T K Mitchen, L R Hall, et al.
Parasite Immunology
|
November 1, 1994
The effect of treating with anti-interleukin-1 receptor antibody on the course of experimental murine cutaneous leishmaniasis
C M Theodos, A Shankar, A L Glasebrook, et al.
The Journal of Clinical Investigation
|
July 1, 1979
In vitro and in vivo refractoriness to thyrotropin stimulation of iodine organification and thyroid hormone secretion
J B Field, A Dekker, G Titus, et al.
The American Journal of Tropical Medicine and Hygiene
|
January 1, 2008
Protection of susceptible BALB/c mice from challenge with Leishmania major by nucleoside hydrolase, a soluble exo-antigen of Leishmania
Mohammad A Al-Wabel, Willy K Tonui, Liwang Cui, et al.
The American Journal of Tropical Medicine and Hygiene
|
December 26, 2003
Short report: requirement of b cells for delayed type hypersensitivity-like pathology after secondary infection with Leishmania major in resistant C57BL/6 mice
Gregory K DeKrey, Jeremy J Jones, M Lamine Mbow, et al.
European Journal of Immunology
|
October 1, 1987
Involvement of specific Lyt-2+ T cells in the immunological control of experimentally induced murine cutaneous leishmaniasis
R G Titus, G Milon, G Marchal, et al.
Parasite Immunology
|
May 13, 1999
Indomethacin treatment slows disease progression and enhances a Th1 response in susceptible BALB/c mice infected with Leishmania major
L A De Freitas, L M Mbow, M Estay, et al.
Infection and Immunity
|
December 1, 1993
An avirulent lipophosphoglycan-deficient Leishmania major clone induces CD4+ T cells which protect susceptible BALB/c mice against infection with virulent L. major
P B Kimsey, C M Theodos, T K Mitchen, et al.
Infection and Immunity
|
March 20, 2001
Major histocompatibility complex class II-independent generation of neutralizing antibodies against T-cell-dependent Borrelia burgdorferi antigens presented by dendritic cells: regulation by NK and gammadelta T cells
M L Mbow, N Zeidner, R D Gilmore, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 138) with videos related to
Sort By:
Page
of 14
Proceedings of the National Academy of Sciences of the United States of America
|
October 24, 1995
Development of a safe live Leishmania vaccine line by gene replacement
R G Titus, F J Gueiros-Filho, L A de Freitas, et al.
Molecular and Biochemical Parasitology
|
October 1, 1993
Reversion to virulence in Leishmania major correlates with expression of surface lipophosphoglycan
A Shankar, T K Mitchen, L R Hall, et al.
Parasite Immunology
|
November 1, 1994
The effect of treating with anti-interleukin-1 receptor antibody on the course of experimental murine cutaneous leishmaniasis
C M Theodos, A Shankar, A L Glasebrook, et al.
The Journal of Clinical Investigation
|
July 1, 1979
In vitro and in vivo refractoriness to thyrotropin stimulation of iodine organification and thyroid hormone secretion
J B Field, A Dekker, G Titus, et al.
The American Journal of Tropical Medicine and Hygiene
|
January 1, 2008
Protection of susceptible BALB/c mice from challenge with Leishmania major by nucleoside hydrolase, a soluble exo-antigen of Leishmania
Mohammad A Al-Wabel, Willy K Tonui, Liwang Cui, et al.
The American Journal of Tropical Medicine and Hygiene
|
December 26, 2003
Short report: requirement of b cells for delayed type hypersensitivity-like pathology after secondary infection with Leishmania major in resistant C57BL/6 mice
Gregory K DeKrey, Jeremy J Jones, M Lamine Mbow, et al.
European Journal of Immunology
|
October 1, 1987
Involvement of specific Lyt-2+ T cells in the immunological control of experimentally induced murine cutaneous leishmaniasis
R G Titus, G Milon, G Marchal, et al.
Parasite Immunology
|
May 13, 1999
Indomethacin treatment slows disease progression and enhances a Th1 response in susceptible BALB/c mice infected with Leishmania major
L A De Freitas, L M Mbow, M Estay, et al.
Infection and Immunity
|
December 1, 1993
An avirulent lipophosphoglycan-deficient Leishmania major clone induces CD4+ T cells which protect susceptible BALB/c mice against infection with virulent L. major
P B Kimsey, C M Theodos, T K Mitchen, et al.
Infection and Immunity
|
March 20, 2001
Major histocompatibility complex class II-independent generation of neutralizing antibodies against T-cell-dependent Borrelia burgdorferi antigens presented by dendritic cells: regulation by NK and gammadelta T cells
M L Mbow, N Zeidner, R D Gilmore, et al.
Page
of 14